Data presented at the 2025 American Epilepsy Society Annual MeetingPLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the presentation of ...
MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today ...
Objective response rate (ORR) of 75.0% including three very good partial responses (VGPR) in heavily pre-treated Waldenström ...
When weird fungal epidemics crop up in far-flung places, scientists work together to unravel how the microscopic murderers ...
Humans are, in effect, hardwired to sing and dance, and we likely evolved to do so. In every known culture, evidence exists ...
Denali's validated platform, strategic pipeline, and experienced management present a compelling long-term investment opportunity. Find out why DNLI stock is a Buy.
Confusion over NEET's role in Psychology education highlights systemic flaws in India's allied healthcare admissions and ...
The writer’s stay was hosted by Persona Jiwa.    I should know better. As a time management expert and bestselling author of ...
Driven by family and service, Courtney Castelli prepares to lead Roxana schools’ future ...
Chinese immigrant mothers in Southern California seeking care face language barriers, billing fights and fear of using public ...
On a cold night in early 2020, in a small town outside Amsterdam, Eugene Koning sat shivering and alone on the front steps of ...
Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival ...